Concomitant Dopaminergic and Glucocorticoid Control of Pituitary Proopiomelanocortin Messenger Ribonucleic Acid and β-Endorphin Levels*
- 1 November 1987
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 121 (5) , 1689-1696
- https://doi.org/10.1210/endo-121-5-1689
Abstract
Synthesis and secretion of POMC-derived peptides appear to be differentially regulated in the anterior pituitary (AP) and neurointermediate lobe (NIL). In the AP, glucocorticoids inhibit, and CRF and arginine vasopressin stimulate, synthesis of POMC and release of immunoreactive (ir)-.beta.-endorphin (.beta.EP); in the NIL, synthesis and release of POMC and its derivatives are under tonic inhibitory dopaminergic control. There is, however, evidence for some overlap of these control mechanisms under certain circumstances. In the present study we have used specific RIA and Northern blot analysis to examine the effects of chronic treatment with dopaminergic agents and dexamethasone (DM) (both alone and in combination) on AP and NIL content of ir-.beta.EP and POMC messenger RNA (mRNA), and/or hypothalamic ir-arginine vasopressin and ir-CRF content. In the NIL, the dopamine agonist bromocriptine reduced and the antagonist haloperidol raised both POMC mRNA and ir-.beta.EP content. Long term DM treatment did not alter NIL ir-.beta.EP content in the intact rat, but increased levels of POMC mRNA. DM abolished the haloperidol-induced increase in NIL ir-.beta.EP content but further increased the haloperidol-induced rise in POMC mRNA. DM treatment lowered both ir-.beta.EP and POMC mRNA in the AP as well as lowering levels of hypothalamic ir-CRF. In DM-treated rats, haloperidol partially restored AP ir-.beta.EP and POMC mRNA to control untreated levels. These findings further support the proposition that both dopaminergic agents and glucocorticoids can modulate POMC mRNA levels and/or tissue content of ir-.beta.EP in both the NIL and AP of the rat. The effects of DM on the NIL, both alone or with haloperidol, suggest that glucocorticoids may have both direct and indirect effects on POMC gene expression in this tissue.This publication has 28 references indexed in Scilit:
- Dopaminergic control of prolactin mRNA accumulation in the pituitary of the male ratMolecular and Cellular Endocrinology, 1981
- Differential control of β-endorphin/β-lipotropin secretion from anterior and intermediate lobes of the rat pituitary gland in vitroLife Sciences, 1980
- Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.Proceedings of the National Academy of Sciences, 1980
- Storage and secretion of β-endorphin and related peptides by mouse pituitary tumor cells: Regulation by glucocorticoidsArchives of Biochemistry and Biophysics, 1980
- Parallel release of ACTH, β-endorphdm, α-MSH and β-MSH-like immunoreactivities in rat anterior pituitary cells in cultureMolecular and Cellular Endocrinology, 1979
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979
- Selective reduction of proadrenocorticotropin/endorphin proteins and messenger ribonucleic acid activity in mouse pituitary tumor cells by glucocorticoidsBiochemistry, 1979
- Studies on the Site of Action of Vasopressin in Inducing Adrenocorticotropin Secretion*Endocrinology, 1978
- An Improved Radioimmunoassay for α-Melanocyte-Stimulating Hormone (α-MSH) in the Rat: Serum and Pituitary α-MSH Levels after Drugs Which Modify Catecholaminergic NeurotransmissionNeuroendocrinology, 1978
- β-Endorphin and Adrenocorticotropin Are Selected Concomitantly by the Pituitary GlandScience, 1977